23 March 2022: Articles
A Rare Case of Listeria Septicemia and Meningitis in Liver Cirrhosis
Rare coexistence of disease or pathology
Ariana R. Tagliaferri1ABDEF*, Rovena Pjetergjoka1EF, Konstantinos Leou1EFDOI: 10.12659/AJCR.935198
Am J Case Rep 2022; 23:e935198
Abstract
BACKGROUND: Sepsis is a leading global cause of mortality, with the most common causative agents being Staphylococcus aureus, Streptococcus pneumoniae, and Escherichia coli. In septic patients with liver cirrhosis, the mortality rates are higher than in the general population due to altered liver function and an excessive innate immune response. In this demographic, sepsis is typically caused by spontaneous bacterial peritonitis or urinary tract infections and the causative agents are very predictable owing to known dysregulated immunological pathways studied in patients with cirrhosis. Listeria monocytogenes is not only a less common cause of sepsis, but also a rare cause in patients with cirrhosis. Moreover, concurrent meningitis and septicemia is even less common in this demographic.
CASE REPORT: Herein we present a patient with known liver cirrhosis from chronic alcohol use who presented with generalized complaints and was admitted to the Intensive Care Unit with septic shock and concomitant liver failure. Although his changes in mentation were initially attributed to sepsis with superimposed hepatic encephalopathy, he was also diagnosed with meningitis. Cultures from the cerebral spinal fluid and blood serum were positive for Listeria monocytogenes. The patient’s family reported that he had not recently consumed deli meat, cheeses, or raw chicken, and there were no known outbreaks in the area at the time of diagnosis.
CONCLUSIONS: This report illustrates a rare case of concurrent septicemia and meningitis secondary to Listeria monocytogenes in a patient with liver cirrhosis and reviews current literature.
Keywords: Listeria monocytogenes, Liver Cirrhosis, Alcoholic, Meningitis, Bacterial, Sepsis, hepatic encephalopathy, Hepatitis, Humans, Listeria, Liver Cirrhosis, Male, Meningitis, peritonitis
Background
Sepsis is an infection of the bloodstream, which can lead to multi-organ failure and death [1–5]. This disease has a major global healthcare impact and is associated with a greater than 40% mortality rate, regardless of causative agents [2]. Despite appropriate measures to reduce the spread of infections worldwide, the incidence of sepsis remains high [2]. Early recognition and diagnosis is imperative to prevent death [2]. Circulating proinflammatory cytokines and acute phase reactants alter microvascular blood flow, leading to sepsis-induced multi-organ failure [3]. Global tissue dysoxia is caused by a reduction in functional capillary density, increased permeability and apoptosis of the endothelial cells, adherence of activated neutrophils to the endothelial layer, activation of clotting cascades, and deposition of microthrombi [3]. During shock, all macro-vascular blood flow is decreased by approximately 50% [3]. The liver plays a major role in metabolizing host defense mechanisms and toxins during sepsis; however, with underlying liver cirrhosis, there is not only liver dysfunction but also an excessive response of the innate immune system [3,4]. Previous studies have demonstrated increased mortality from sepsis in patients with cirrhosis, regardless of bacterial pathogen [4].
Alcohol abuse can also suppress the immune system owing to depressed phagocytic activity against gram-negative and gram-positive bacteria, and, due to underlying poor liver function, the ability to remove toxins is also impaired [1]. This increases the risk of sepsis and meningitis, even from
Herein, we report a case of a man with liver cirrhosis who developed an uncommon cause of sepsis with subsequent liver shock and was found to have concomitant meningitis.
Case Report
A 64-year-old man with a past medical history of hypertension with medication non-adherence and liver cirrhosis with active alcohol use disorder, presented to the Emergency Department with acute mild and intermittent chest pain associated with dizziness, nausea, and palpitations. The pain started the morning prior to presentation and initially resolved spontaneously but re-emerged throughout the next day. His last shot of alcohol was 3 days prior to admission, and he reported drinking 1 shot of ethanol 3 times weekly. The patient reported a recent increased use of acetaminophen for generalized chronic body aches as well, although he was unable to quantify the amount. Additionally, the patient denied use of herbal supplements, vitamins, and other over-the-counter medications. On arrival, the patient was alert and oriented and the examination was unremarkable, per the admitting team. He was hemodynamically stable with the following vital signs: temperature of 38.7°C (temporal artery), heart rate of 94 beats per min, respiratory rate of 18 breaths per min, blood pressure of 113/55 mmHg, and peripheral oxygen saturation of 97% on room air. Admission laboratory results were significant for an elevated high sensitivity troponin (57 pg/mL), normocytic anemia (hemoglobin 9.2 g/dL, MCV 84 fL), thrombocytopenia (26 K/mm3), hypertriglyceridemia (227 mg/dL, HDL <8 mg/dL), hyponatremia (133 mEq/L), hypoalbuminemia (3.2 g/dL), elevated liver function enzymes (ALP 117 unit/L, AST 900 unit/L, ALT 169 unit/L), and hyperbilirubinemia (4.8 mg/dL). Creatinine kinase, brain natriuretic peptide, and lipase levels were all within normal limits. Of note, the patient’s baseline hemoglobin was approximately 9 to 10 g/dL, baseline platelets were 20 to 30 K/mm3, and he initially did not require transfusion while inpatient, as there was no indication of an active bleed. An electrocardiogram showed normal sinus rhythm with left axis deviation that was unchanged from previous imaging and no ST- or T-wave changes. The chest X-ray was unremarkable. He was admitted to the medical floors with non-ST-elevation myocardial infarction and demand ischemia. A 2-dimensional echocardiogram and transesophageal echocardiogram revealed preserved ejection fraction with severe left ventricular hyper-trophy, impaired diastolic dysfunction, and no evidence of valvular defects or stigmata of infective endocarditis. The patient was scheduled for a stress test; however, he was noted to be lethargic the day following admission, for which the Critical Care Unit was consulted for acute encephalopathy. During assessment, the patient was intermittently agitated, confused, and lethargic on examination. He was slightly febrile, with a temperature of 39.2°C, and tachycardic (108 beats per min), and had a blood pressure of 76/41 mmHg. He was euvolemic, with scleral icterus and jaundice, and the abdomen was soft and non-tender with normoactive bowel sounds but distended with shifting dullness. At this stage, most recent laboratory results were remarkable for worsening liver enzymes (ALP 131 unit/L, AST 4698 unit/L, ALT 1143 unit/L, total bilirubin 12.7 mg/dL), an ammonia level of 166 mcmol/L, lactic acid of 5.7 mmol/L, procalcitonin of 11.33 ng/mL, acetaminophen level <10 mcg/mL, salicylate level <2.5 mg/dL, new acute renal failure (BUN 22 mg/dL, creatinine 1.54 mg/dL), and leukocytosis of 33.9×103/mm3, with segmented neutrophils of 78% and bands of 17%. He was transferred to the Intensive Care Unit for liver shock and multi-factorial encephalopathy. A computerized tomography scan of the brain without contrast did not reveal gross intracranial hemorrhage, midline shift, or hydro-cephalus. Owing to worsening lethargy, the patient was intubated for airway protection and started on vasopressors (norepinephrine) for hemodynamic instability secondary to sepsis. The patient was initially treated with NAC, rifaximin, and lactulose and placed on empiric antibiotics (intravenous vancomycin 1000 mg daily and cefepime 500 mg daily), until blood cultures returned positive for
Discussion
Bacterial infections are an important complication of cirrhosis, especially in hospitalized patients, as they are prone to sepsis-related organ failure, including ischemic hepatitis [3,4]. During sepsis, the liver metabolizes, produces, and releases cytokines and acute phase reactants leading to structural and functional injury [3]. The sinusoidal cells become swollen and clogged with acute phase reactants, causing leakage of albumin and toxins and directly damaging tissue [4]. Additionally, alterations in the hepatic macro- and microcirculation are present during sepsis owing to high amounts of circulating nitric oxide, endothelin-1, and carbon monoxide [3]. This is problematic in cirrhosis because patients with cirrhosis tend to have high cardiac output, low arterial pressure, and low systemic vascular resistance. Thus, the presence of these toxins will further decrease perfusion and blood flow velocity in the liver sinusoids and allow endothelial invasion of neutrophils and microthrombi, which ultimately exacerbate tissue ischemia and induce damage [1,3]. Infection is more common in de-compensated liver cirrhosis than in compensated liver cirrhosis because the ability to present antigens via monocyte HLADR expression is downregulated and there are deficiencies in complement expression [1]. Moreover, in alcohol-induced cirrhosis, specifically, there is depressed neutrophil phagocytosis and intracellular killing of gram-positive or gram-negative bacteria [1]. High amounts of circulating proinflammatory cytokines also lead to the development of renal failure, acute lung injury, hepatic encephalopathy, sepsis-induced hyperglycemia, defective arginine vasopressin secretion, adrenal insufficiency, and compartmental syndrome [1]. This was the case in our patient, who developed renal failure from acute tubular necrosis and rhabdomyolysis in the setting of sepsis, rather than any underlying heart disease. Additionally, our patient eveloped hepatic encephalopathy with elevated ammonia levels and altered mental status, which unfortunately did not improve despite treatment with NAC, rifaximin, and lactulose.
The most common bacterial infection in liver cirrhosis is spontaneous bacterial peritonitis, which is frequently caused by
Conclusions
In this case report, we present a patient with liver cirrhosis who developed multi-factorial encephalopathy and liver shock in the setting of
References:
1.. Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R, Severe sepsis in cirrhosis: Hepatology, 2009; 50; 2022-33
2.. Napolitano LM, Sepsis 2018: Definitions and guideline changes: Surg Infect (Larchmt), 2018; 19; 117-25
3.. Spapen H, Liver perfusion in sepsis, septic shock, and multiorgan failure: Anat Rec (Hoboken), 2008; 291; 714-20
4.. Tandon P, Garcia-Tsao G, Bacterial infections, sepsis, and multiorgan failure in cirrhosis: Semin Liver Dis, 2008; 28; 26-42
5.. Yildiz O, Aygen B, Esel D: Yonsei Med J, 2007; 48; 433-39
6.. van de Beek D, Cabellos C, Dzupova O, ESCMID guideline: Diagnosis and treatment of acute bacterial meningitis: Clin Microbiol Infect, 2016; 22(Suppl. 3); S37-62
7.. Huang YT, Kuo YW, Lee MR, Clinical and molecular epidemiology of human listeriosis in Taiwan: Int J Infect Dis March, 2021; 104; 718-24
8.. Chen SY, Lee JJ, Chien CC: J Clin Neurosci, 2020; 71; 177-85
9.. Charlier C, Fevre C, Travier L, Listeria monocytogenes-associated biliary tract infections: A study of 12 consecutive cases and review: Medicine (Baltimore), 2014; 93; e105
10.. Mitrović M, Đurić P, Janković A, Unusual Listeria monocytogenes peritonitis in peritoneal dialysis patient with liver cirrhosis: A case report and review of literature: CEN Case Rep, 2017; 6; 115-17
11.. Pagliano P, Boccia G, De Caro F, Esposito S, Bacterial meningitis complicating the course of liver cirrhosis: Infection, 2017; 45; 795-800
In Press
Case report
Focal Autoimmune Pancreatitis Morphologically Mimicking Pancreatic Cancer: A Case Report and Literature ReviewAm J Case Rep In Press; DOI: 10.12659/AJCR.944286
Case report
Amyloidosis Found in the Breast: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.944755
Case report
Musculoskeletal Pain and Right Leg Paresthesia Revealed as Large Ovarian Mucinous Cystadenoma: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.945083
Case report
Pathological Complete Response with Neoadjuvant Trastuzumab, Pertuzumab, and Chemotherapy Followed by Modif...Am J Case Rep In Press; DOI: 10.12659/AJCR.943936
Most Viewed Current Articles
07 Mar 2024 : Case report 41,616
Neurocysticercosis Presenting as Migraine in the United StatesDOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report 32,211
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
23 Feb 2022 : Case report 19,335
Penile Necrosis Associated with Local Intravenous Injection of CocaineDOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
19 Jul 2022 : Case report 18,591
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128